Table 1.
Echocardiographic analyses of 2‐month meth treatment
Female PBS | Female meth | P value | Male PBS | Male meth | P value | |
---|---|---|---|---|---|---|
EF, % | 97.2 (±0.36) | 95.2 (±1.3) | 0.11 | 97.8 (±0.51) | 94.8 (±0.66) | 0.12 |
FS, % | 78.04 (±1.8) | 69.09 (±2.1) | 0.10 | 79.3 (±1.5) | 68.0 (±1.5) | 0.01* |
LVID;d, mm | 2.50 (±0.16) | 2.73 (±0.08) | 0.48 | 2.61 (±0.03) | 2.75 (±0.10) | 0.30 |
LVID;s, mm | 0.55 (±0.03) | 0.84 (±0.06) | 0.07 | 0.47 (±0.08) | 0.88 (±0.04) | 0.05 |
PBS, phosphate‐buffered saline; EF, ejection fraction; FS, fractional shortening; LVID;d, left ventricular end‐diastolic internal diameter, LVID;s, left ventricular end‐systolic internal diameter. Data are expressed as mean ± SEM and analyzed using a two‐tailed paired t test.